A First-in-Human Study to Assess Single and Multiple Doses of NXC736 in Healthy Participants

NCT05079425 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: NXC736
DRUG: Placebo

Sponsor

NEXTGEN Bioscience